Lawrence Edwards, MD, discusses the importance of addressing pain in patients with gout and the role of collaboration between clinical specialties during the management of painful gout flares.
Suneet Grewal, MD, provides a deeper insight into the impact of uncontrolled gout on the quality of life of patients and the importance of having an open dialogue.
Researchers estimated the proportion of incident gout cases that could be prevented by modification of obesity and other key risk factors.
Of 25 patients with both obesity and gout who had elevated uric acid levels prior to bariatric surgery, 10 achieved therapeutic target levels of uric acid at 12 months after the surgery, according to investigators.
Researchers determined the association between gout and epilepsy and the risk for epilepsy in patients with gout.
Gout incidence rate significantly reduced with SGLT2 inhibitor vs GLP-1 receptor agonist.
Gout more than doubles the risk for end-stage kidney disease.
Venous thromboembolism risk similar for patients with gout regardless of urate-lowering therapy.
A diagnosis of incident or new chronic pain may be twice as likely in patients with vs without gout.
Researchers evaluated the efficacy and safety of anakinra for the treatment of acute gout flares.
